Suppr超能文献

CYP2D6基因多态性对马来西亚精神分裂症患者症状学及副作用的影响。

Influence of CYP2D6 polymorphisms on symptomatology and side-effects of patients with schizophrenia in Malaysia.

作者信息

Zahari Zalina, Salleh Mohd Razali, Teh Lay Kek, Ismail Rusli

机构信息

Pharmacogenetics Research Group, Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia Health Campus & Department of Pharmacy, Hospital Universiti Sains Malaysia, Universiti Sains Malaysia Health Campus, Jln Raja Perempuan Zainab II, 16150 Kubang Kerian, Kelantan, Malaysia.

出版信息

Malays J Med Sci. 2009 Jul;16(3):12-20.

Abstract

BACKGROUND

Our objective was to investigate the association of CYP2D6 polymorphisms with symptoms and side-effects of patients with schizophrenia.

METHODS

The subjects were 156 patients with schizophrenia undergoing antipsychotic treatment at a psychiatric clinic. Patients with co-morbid diagnoses of substance abuse or mental retardation were excluded from the study. Psychopathology was evaluated using the Positive and Negative Symptoms Scale (PANSS). Extrapyramidal side-effects and akathisia were assessed with the Simpson Angus Scale (SAS) and the Barnes Akathisia Rating Scale (BARS), respectively. DNA was extracted from blood and subjected to PCR-genotyping.

RESULTS

We found that CYP2D6 polymorphisms were significantly associated with a subtotal negative PANSS score. In addition, CYP2D6 is not related to side-effects of antipsychotic therapy, or SAS and BARS scores. The results suggest that CYP2D6 polymorphisms may have implications in treatment response.

CONCLUSIONS

Therefore, CYP2D6 may be a predictor for treatment outcomes of patients with schizophrenia. However, further investigation is required to confirm these findings in a larger sample.

摘要

背景

我们的目的是研究CYP2D6基因多态性与精神分裂症患者症状及副作用之间的关联。

方法

研究对象为156名在精神科诊所接受抗精神病药物治疗的精神分裂症患者。共病有药物滥用或智力发育迟缓诊断的患者被排除在研究之外。使用阳性和阴性症状量表(PANSS)评估精神病理学。分别使用辛普森·安格斯量表(SAS)和巴恩斯静坐不能评定量表(BARS)评估锥体外系副作用和静坐不能。从血液中提取DNA并进行PCR基因分型。

结果

我们发现CYP2D6基因多态性与PANSS总分阴性显著相关。此外,CYP2D6与抗精神病治疗的副作用或SAS和BARS评分无关。结果表明CYP2D6基因多态性可能对治疗反应有影响。

结论

因此,CYP2D6可能是精神分裂症患者治疗结果的一个预测指标。然而,需要进一步研究以在更大样本中证实这些发现。

相似文献

8
Risperidone plasma levels, clinical response and side-effects.利培酮血药浓度、临床反应及副作用。
Eur Arch Psychiatry Clin Neurosci. 2005 Aug;255(4):261-8. doi: 10.1007/s00406-004-0556-4. Epub 2004 Nov 29.

本文引用的文献

3
Genetics and the future of clinical psychiatry.遗传学与临床精神病学的未来。
Am J Psychiatry. 2006 Oct;163(10):1676-8. doi: 10.1176/ajp.2006.163.10.1676.
5
Current schizophrenia drugs: efficacy and side effects.当前的精神分裂症药物:疗效与副作用。
Expert Opin Pharmacother. 2006 Jun;7(8):1005-16. doi: 10.1517/14656566.7.8.1005.
9
Finding schizophrenia genes.寻找精神分裂症相关基因。
J Clin Invest. 2005 Jun;115(6):1440-8. doi: 10.1172/JCI24759.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验